Mohammad NAJAFIZADEH, Bahador SARKARI, Naser FARHADI

Association of HLA- B7, B8, B27 and B51 with Genetic Protection Against Hepatitis B Virus

It is generally believed that viral clearance or chronic infection following hepatitis B virus (HBV) infection is linked to the genetic background of the host and human leukocyte antigens (HLA) play a central role. This study was conducted to determine associations between some of HLA classI genes with the outcome of hepatitis B infection. Subjects of this study were 64 individuals who were assigned into two group, case and con trol, based on their clinical and ser ologic profiles. Case gr oup were 27 p atients infected with HBV and controls were 37 subjects with HBV natural convalescent who recovered from a HBV in fection. Ty ping of HLA cla ss I was performed b y serol ogic method. No significant difference was f ound between mean age of co ntrol and patie nt group while th e differ ence in sex of two groups was significant (P

PDF

___

[1] World He alth Organ ization. 2004. Hepatitis B vaccines. Wkly Epidemiol Rec. 79:263.
[2] Raza SA, Clifford GM, Franceschi S. 2007. Worldwide vari ation in the r elative im portance of hepatitis B and hepatitis C viru ses in hepato cellular carcinoma: a systematic rev iew. Br J Ca ncer. 96:1127-34.
[3] Safioleas M, Lygidakis NJ, Manti C. 2007. Hepatitis B today. Hepatogastroenterology. 54:545-8.
[4] He YL, Zhao YR, Zhang SL, Lin SM. 2006. Host susceptibility to persistent hepatitis B virus infection . World J Gastroenterol. 12:4788-93.
[5] Frodsham AJ. 2005. Host g enetics and the outcome of hepatitis B viral infection. Transpl Immunol. 14:183- 6.
[6] Thursz M. 2001. Genetic sus ceptibility in chronic viral hepatitis. Antiviral Res. 52:113-6.
[7] Thio CL, Thomas DL, Kar acki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. 2003. Comprehensive analy sis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 77:12083-7.
[8] Wang FS. 2003. Current status and pro spects of studies on hum an gene tic al leles as sociated with hepatitis B viru s infection . W orld J Gastroent erol. 9:641-4.
[9] Karan MA, Tascioglu NE , Ozturk AO, Palanduz S, Carin M. 2002. The role of HLA antigens in chronic hepatitis B viru s infection . J Pak Med Assoc. 52: 253-6.
[10] Bertoletti A, Gehring A. 2007. Immune response and tolerance dur ing chronic hep atitis B virus infection. Hepatol Res. 3:331-8.
[11] Mota AH, Fainboim H, Terg R, Fainboim L. 1987. Association of chronic active hepatitis and HLA B35 in pati ents with hepati tis B vir us. Tissue Anti gens. 30:238-40.
[12] van Hattum J, Schre uder GM, Schalm SW. 1987. HLA antigens i n pati ents with various courses after hepatitis B virus infection. Hepatology. 7:11-4.
[13] Hwang SH, Sohn YH, Oh HB, Hwang CY, Lee SH, Shin ES, Lee KJ. 2007. Human leuko cyte an tigen alleles and h aplotypes as sociated with chronicity of hepatitis B virus infection in Koreans. Arch Patho l Lab Med. 131:117-21.
[14] Karan MA, Tascioglu NE , Ozturk AO, Palanduz S, Carin M. 2002. The role of HLA antigens in chronic hepatitis B vir us infec tion. J Pak Med As soc. 52:253-6.
[15] Akcam Z, Sunbul M, Dur upinar B, Eroglu C, Esen S, Leblebicioglu H . 2002. Tissue types as progno stic risk factor in h epatitis B virus infec tion. Indi an J Gastroenterol. 21:139-41.